1. Home
  2. MATW vs IRWD Comparison

MATW vs IRWD Comparison

Compare MATW & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MATW

Matthews International Corporation

HOLD

Current Price

$25.35

Market Cap

824.4M

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.41

Market Cap

663.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATW
IRWD
Founded
1850
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
824.4M
663.6M
IPO Year
1995
2009

Fundamental Metrics

Financial Performance
Metric
MATW
IRWD
Price
$25.35
$3.41
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
222.9K
2.5M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
3.67%
N/A
EPS Growth
59.07
1400.00
EPS
0.69
0.24
Revenue
$1,795,737,000.00
$298,276,000.00
Revenue This Year
N/A
$57.95
Revenue Next Year
N/A
$4.39
P/E Ratio
$36.87
$13.50
Revenue Growth
N/A
8.88
52 Week Low
$20.76
$0.58
52 Week High
$30.93
$5.78

Technical Indicators

Market Signals
Indicator
MATW
IRWD
Relative Strength Index (RSI) 34.93 40.18
Support Level $25.38 $3.02
Resistance Level $26.34 $3.53
Average True Range (ATR) 0.78 0.19
MACD -0.21 -0.06
Stochastic Oscillator 14.80 26.04

Price Performance

Historical Comparison
MATW
IRWD

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: